When Incyte Genomics, then a bioinformatics company based in Palo Alto, California, acquired Synteni for $90m in 1997, Affymetrix immediately sued Incyte for patent infringement.

所以当Incyte Genomics，一个同样位于帕洛阿尔托的生物技术公司于1997年以9000万美元的价格收购Synteni时，Affymetrix马上作出以专利侵权起诉了Incyte公司。

youdao

Meanwhile, Incyte, a pharmaceutical company in Wilmington, Delaware, presented promising results from a smaller trial of its own kinase inhibitor. And a paper published in September by the.

与此同时，特拉华州威尔明顿的Incyte制药公司，提出了自己的激酶抑制剂小范围试验的良结果。

youdao

Next, it will use a database of genes maintained by Incyte Pharmaceuticals, in Palo Alto, Calif.

FORBES: A hail of silver bullets

The next step in Zeneca's research called for another service conveniently available at Incyte.

FORBES: Biology in silico

Incyte also plans to tests its drug in treatment resistant forms of this disease.

FORBES: The Next Big Rare Disease Drug?